Skip to main content

Fight against mycobacterial diseases

A large part of our research is dedicated to the fight against mycobacterial infections by characterizing enzymes essential to mycobacterial physiology, which represent potential targets for the development of new drugs, particularly antituberculosis drugs. Other players, e.g. a new family of toxins not related to mycobacteria, are also investigated.